Capsulomics

Capsulomics is commercializing the first diagnostic platform that can both detect upper gastrointestinal diseases and accurately predict the risk of disease progression to more complex forms, including cancer. Their test is inexpensive, accurate, and accessible to non-clinical personnel. The purpose of the Capsulomics test is to enable early detection of diseases by patients and clinicians while the conditions are still treatable.